Results 131 to 140 of about 6,804 (189)

Flow-induced Klf4-Akt signaling links EC cycling to mural cell defects in arterial-venous malformations. [PDF]

Theranostics
Lin Y, Hashemi Z, Zhang Q, Di Y, Behera T, Gahn J, Banerjee K, Wu F, Andorfer K, Singhal M, Seebauer C, Ola R.   +11 more
europepmc   +1 more source

Propranolol Reduces Epistaxis in Hereditary Hemorrhagic Telangiectasia: A Large Retrospective Study. [PDF]

J Clin Med
Serra MM, Pagotto V, Botella LM, Bernabeu C.   +3 more
europepmc   +1 more source

Unusual Onset of Hereditary Hemorrhagic Telangiectasia Due to Somatic Mutational Mosaicism: Case Report and Review of the Literature. [PDF]

Children (Basel)
Mirra V, Rosa M, Fontanella C, Mancuso M, Antonelli F, Castaldo A, Allegorico A, Russo MG, Giordano M, Tirozzi A, Siani P, De Brasi D.   +11 more
europepmc   +1 more source

Nonlinear model reduction for large-scale structures via dual substructuring. [PDF]

Sci Rep
Flores PA.
europepmc   +1 more source

Advances in the Genetics and Molecular Biology of Brain Arteriovenous Malformations. [PDF]

Transl Stroke Res
Tsuchiya T, Miyawaki S, Ono H, Hongo H, Ogawa S, Sakai Y, Hirano Y, Sato D, Hirata S, Koizumi S, Saito N.   +10 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Treatment of Recurrent Epistaxis in HHT

Current Pharmaceutical Design, 2006
No optimal treatment modality is currently available for the treatment of recurrent epistaxis in HHT. In this review, different therapeutic concepts are discussed together with their pathophysiologic background. Patients often profess a preventive effect for nasal ointments and use packings which can be self-administered in the case of bleeding.
GEISTHOFF UW, FIORELLA R., FIORELLA, Maria Luisa   +2 more
openaire   +2 more sources